Avidity Biosciences (RNA) Research & Development (2019 - 2025)
Historic Research & Development for Avidity Biosciences (RNA) over the last 7 years, with Q3 2025 value amounting to $154.9 million.
- Avidity Biosciences' Research & Development rose 10071.76% to $154.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $488.2 million, marking a year-over-year increase of 8719.87%. This contributed to the annual value of $303.6 million for FY2024, which is 5897.58% up from last year.
- As of Q3 2025, Avidity Biosciences' Research & Development stood at $154.9 million, which was up 10071.76% from $138.1 million recorded in Q2 2025.
- Avidity Biosciences' 5-year Research & Development high stood at $154.9 million for Q3 2025, and its period low was $20.7 million during Q1 2021.
- Over the past 5 years, Avidity Biosciences' median Research & Development value was $47.7 million (recorded in 2023), while the average stood at $59.9 million.
- In the last 5 years, Avidity Biosciences' Research & Development soared by 27296.18% in 2021 and then skyrocketed by 724.57% in 2023.
- Quarter analysis of 5 years shows Avidity Biosciences' Research & Development stood at $33.0 million in 2021, then soared by 38.35% to $45.6 million in 2022, then grew by 15.8% to $52.8 million in 2023, then soared by 81.05% to $95.6 million in 2024, then soared by 62.04% to $154.9 million in 2025.
- Its Research & Development was $154.9 million in Q3 2025, compared to $138.1 million in Q2 2025 and $99.5 million in Q1 2025.